Antiamyloid Gantenerumab Disappoints in Phase 3 Trials
The antiamyloid monoclonal antibody gantenerumab led to a lower amyloid plaque burden but no clear cognitive benefit in early Alzheimer's disease in twin pivotal trials.
Source: medscape.com
Page 8 - Iological Marker News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Iological Marker Today - Breaking & Trending Today
White House Appoints New NCI Director
After years of working with the National Cancer Institute, W. Kimryn Rathmell, MD, PhD, gets the call to run the institute.
Source: medscape.com
Novel Blood Test Can Detect Rheumatoid Arthritis
An experimental assay detects epigenetic features within the unique patterns and sizes of cell-free DNA found in blood, but is it better than clinical diagnostics?
Source: medscape.com
PTSD Symptoms in Women Tied to Worse Heart, Brain Health
A study of midlife women found an association between higher posttraumatic stress disorder symptoms and worse cardiovascular and neurocognitive health.
Source: medscape.com
Prurigo Nodularis Dx Delay in Skin Types Gains Significance
Patients with darker skin types tend to have larger nodules that might vary in shape relative to lighter skin types, according to Shawn Kwatra, MD.
Source: medscape.com